Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drugs”

307 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 307 results

Not applicableStudy completedNCT03836443
What this trial is testing

Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)UnknownNCT04896606
What this trial is testing

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Who this might be right for
Covid19
New York Medical College 50
Not applicableUnknownNCT02649725
What this trial is testing

Patients Satisfaction With the Outcomes of Expensive Cytotoxic Agents

Who this might be right for
Patient's Satisfaction
Ain Shams University 1,800
Testing effectiveness (Phase 2)Looking for participantsNCT04267978
What this trial is testing

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Who this might be right for
Glioblastoma, RecurrentLower Grade Glioma, Recurrent
Beijing Sanbo Brain Hospital 109
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT03266640
What this trial is testing

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Who this might be right for
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Early research (Phase 1)Looking for participantsNCT04180059
What this trial is testing

Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Haematologic Disease
Nantes University Hospital 6
Large-scale testing (Phase 3)Ended earlyNCT00450970
What this trial is testing

Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Prostate Cancer
Agennix 344
Testing effectiveness (Phase 2)Looking for participantsNCT06963905
What this trial is testing

Saci Nivo Rela for TNBC

Who this might be right for
Metastatic Triple-negative Breast Cancer
Yale University 60
Early research (Phase 1)Ended earlyNCT02231853
What this trial is testing

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Who this might be right for
Chronic Lymphocytic LeukemiaCML (Chronic Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 12
Early research (Phase 1)Study completedNCT02157792
What this trial is testing

M6620 First in Human Study

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 200
Not applicableUnknownNCT00489151
What this trial is testing

Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

Who this might be right for
Hepatitis B
Hospital Authority, Hong Kong 70
Testing effectiveness (Phase 2)UnknownNCT05915481
What this trial is testing

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Who this might be right for
Advanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint Inhibitor+2 more
Peking University Third Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05688241
What this trial is testing

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Who this might be right for
EBV LymphomaPost-transplant Lymphoproliferative Disease (PTLD)
University Hospital, Basel, Switzerland 10
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05554419
What this trial is testing

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Arising From Previous Myeloproliferative Neoplasm+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03116529
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Maryland, Baltimore 22
Not applicableStudy completedNCT00516945
What this trial is testing

Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Who this might be right for
Hepatitis BNeoplasms
Hospital Authority, Hong Kong 110
Testing effectiveness (Phase 2)Study completedNCT00363051
What this trial is testing

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Who this might be right for
Islet Cell CarcinomaNeuroendocrine CarcinomaNeuroendocrine Tumor+1 more
Novartis Pharmaceuticals 160
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Load More Results
184